BPG is committed to discovery and dissemination of knowledge
Brief Article
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 28, 2012; 18(20): 2517-2525
Published online May 28, 2012. doi: 10.3748/wjg.v18.i20.2517
Table 5 Results of patient questionnaire n (%)
VariableOverall
Excluding patients with severe constipation
P value
A (mosapride)B (placebo)C (mosapride)D (placebo)A vs BC vs D
No. of patients124125108120
Compliance > 80%120 (96.8)119 (95.2)105 (97.2)114 (95.0)NSNS
100% intake112 (90.3)115 (92.0)97 (89.8)110 (91.7)NSNS
Any symptom
Nausea5 (4.0)6 (4.8)3 (2.7)4 (3.3)NSNS
Vomiting01 (0.8)00NSNS
Distension40 (32.3)31 (24.8)31 (28.7)28 (23.3)NSNS
Abdominal pain4 (3.2)2 (1.6)3 (2.8)2 (1.7)NSNS
Circulatory reactions0000NSNS
Willingness to repeat the same regimen 77/115 (66.9) 82/112 (73.2) 67/100 (67.0) 79/108 (73.1)NSNS
How easy/difficult to take preparation compared with previous one (easy/invariable/difficult) 34/42/10 24/67/7 32/37/8 23/66/5< 0.05< 0.05


Write to the Help Desk